Literature DB >> 10757921

Operations that are Questionable for Control of Obesity.

.   

Abstract

At the last review of the literature, there were 43 different operations or modifications thereof used for the control of obesity. An effective operation for obesity control should produce a significant weight loss (>/= 25% excess weight loss) to ameliorate the associated medico-sociopsycho-economic ramifications of the obesity. The operative and postoperative significant morbidity should be less than 20% and mortality less than 1%. The weight lost should be maintained for a long period (>/= 5 years). The effects of the operation should be reproducible and documentable by more than two authors working independently. For the purpose of this paper, operations which do not meet these criteria are considered questionable and not recommended for general use. Based on these criteria, questionable operations for treatment of obesity include: tooth wiring, acupuncture, hypothalamic center manipulation, liposuction, balloon insertion, unbanded gastric partitioning, vagotomy, gastrogastrostomy, horizontal gastroplasty, gastric wrap, gastroclip, and any variety of gastroplasty without a reinforced stoma, intestinal bypass, duodenal bypass and biliointestinal bypass. Data to substantiate this classification will be presented and discussed. Since the surgical treatment of obesity is evolving, there is need to collect data from and make modifications to improve the effects of all operations. There is not enough data at this time to prohibit the use of any operation, but the data presented will justify limiting the use of certain operations to institutions dedicated to meticulous follow-up and research.

Entities:  

Year:  1993        PMID: 10757921     DOI: 10.1381/096089293765559593

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  9 in total

1.  Long-term results and complications following adjustable gastric banding.

Authors:  Monika Lanthaler; Franz Aigner; Johann Kinzl; Michael Sieb; Ferguel Cakar-Beck; Hermann Nehoda
Journal:  Obes Surg       Date:  2010-08       Impact factor: 4.129

2.  SAGES guideline for clinical application of laparoscopic bariatric surgery.

Authors: 
Journal:  Surg Endosc       Date:  2008-10       Impact factor: 4.584

3.  Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

4.  Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass?

Authors:  Mathieu André D'Hondt; Hans Pottel; Dirk Devriendt; Frank Van Rooy; Franky Vansteenkiste
Journal:  Obes Surg       Date:  2010-01-08       Impact factor: 4.129

5.  11-year experience with laparoscopic adjustable gastric banding for morbid obesity--what happened to the first 123 patients?

Authors:  Pekka Tolonen; Mikael Victorzon; Jyrki Mäkelä
Journal:  Obes Surg       Date:  2008-01-24       Impact factor: 4.129

Review 6.  Clinical application of laparoscopic bariatric surgery: an evidence-based review.

Authors:  Timothy M Farrell; Stephen P Haggerty; D Wayne Overby; Geoffrey P Kohn; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2009-01-06       Impact factor: 4.584

7.  Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients.

Authors:  J J Rasmussen; W Fuller; M R Ali
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

Review 8.  Use of somatostatin analogues in obesity.

Authors:  Themistoklis Tzotzas; Kostas Papazisis; Petros Perros; Gerasimos E Krassas
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System.

Authors:  Stephanie S Hwang; Mark C Takata; Ken Fujioka; William Fuller
Journal:  Med Devices (Auckl)       Date:  2016-08-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.